Journey Medical Corp
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-312.0K | $-2.2M | $-1.2M | $-2.3M | $-3.8M | $-4.1M | $1.5M | $-2.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $969.0K | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $982.0K | $814.0K |
| Stock-Based Compensation | $1.4M | $989.0K | $1.8M | $1.9M | $1.3M | $1.3M | $1.4M | $1.6M |
| Net Cash from Operating Activities | $-1.7M | $2.9M | $-6.3M | $-2.4M | $-942.0K | $-2.8M | $2.2M | $-1.2M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $158.0K | $220.0K | $5.4M | $7.0M | $165.0K | $3.6M | $10.6M | $-294.0K |
| Net Change in Cash | $-1.6M | $3.1M | $-858.0K | $4.7M | $-777.0K | $765.0K | $-2.2M | $-1.5M |
| Free Cash Flow | — | — | — | — | — | — | — | — |